IUHSA
RARX

Itau Unibanco Holding S.A.’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio RARX Stock Details RARX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,073
Closed -$32K – 1026
2019
Q3 		$32K Hold
1,073
– – ﹤0.01% 251
2019
Q2 		$32K Sell
1,073
-931
-46% -$21.3K ﹤0.01% 563
2019
Q1 		$36K Hold
2,004
– – ﹤0.01% 550
2018
Q4 		$36K Sell
2,004
-115
-5% -$1.8K ﹤0.01% 550
2018
Q3 		$38K Sell
2,119
-54
-2% -$640 ﹤0.01% 554
2018
Q2 		$22K Sell
2,173
-16
-0.7% -$110 ﹤0.01% 669
2018
Q1 		$12K Buy
2,189
+1,483
+210% +$10.6K ﹤0.01% 554
2017
Q4 		$6K Buy
706
+246
+53% +$3.02K ﹤0.01% 530
2017
Q3 		$21K Sell
460
-1,173
-72% -$17.7K ﹤0.01% 609
2017
Q2 		$31K Buy
1,633
+1,473
+921% +$33.2K ﹤0.01% 350
2017
Q1 		$3K Buy
+160
New +$3.06K ﹤0.01% 684

Other funds holding RARX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Itau Unibanco Holding S.A.'s RARX Position: Q4 2019 in Review

Itau Unibanco Holding S.A. sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q4 2019, closing a stake of 1,073 shares — an estimated $32K sold.

Itau Unibanco Holding S.A. first reported a position in RARX in Q1 2017 and held it in 11 quarters. The position peaked at $38K in Q3 2018. 146 funds tracked by Wall St. Rank hold RARX as of Q4 2019.

  • Itau Unibanco Holding S.A. reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 1,073 Ra Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $32K.
  • Itau Unibanco Holding S.A. first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2017 and held it in 11 quarters.
  • Itau Unibanco Holding S.A.'s Ra Pharmaceuticals, Inc. Common Stock position peaked at $38K in Q3 2018.
  • 146 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2019, filed 14 Feb 2020.